baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Swiss Finance & Property Investme.../ CH0032816131 /

2024-03-20 12:00:00 AM	Chg. -	Volume	Bid6:00:04 AM	Ask6:00:04 AM	Market Capitalization	Dividend Y.	P/E Ratio
93.50CHF	-	82 Turnover: -	-Bid Size: -	-Ask Size: -	528.07 mill.CHF	3.98%	101.57

GlobeNewswire 4:34 PM Cicero Institute Applauds Grant's Pass SCOTUS Decision

GlobeNewswire 4:05 PM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AXT

Newsfile Corp 3:49 PM Veta Resources Announces Proposed Reverse-Takeover with Syntheia

Newsfile Corp 3:07 PM Oreo Travel Set to Increase Direct Bookings by 33.77%

GlobeNewswire 3:00 PM MoneyHero Group Announces Strategic Partnership with Jirnexu Pte. Ltd in Malaysian Market

GlobeNewswire 3:00 PM Capricor Therapeutics Announces Long-Term Benefit of Deramiocel (CAP-1002) in Both Skeletal Muscle a...

GlobeNewswire 2:30 PM Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combin...

GlobeNewswire 2:18 PM ECD Auto Design Reports First Quarter 2024 Financial Results; Revenues Increase 207% to Record $8.3 ...

GlobeNewswire 2:00 PM Eyenovia Announces Pricing of $5M Registered Direct Offering

GlobeNewswire 2:00 PM Futureverse and Animoca Brands form strategic partnership with mutual investment to fuel technology ...

GlobeNewswire 1:55 PM Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment

GlobeNewswire 1:00 PM Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for...

GlobeNewswire 1:00 PM Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes

GlobeNewswire 1:00 PM Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Di...

GlobeNewswire 1:00 PM Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphom...

GlobeNewswire 12:30 PM ARS Pharmaceuticals Announces EURneffy (adrenaline nasal spray) Recommended for Approval by CHMP for...

GlobeNewswire 1:39 AM “LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China

GlobeNewswire 1:00 AM Worldwide License Agreement for EA1080, Oral Selective α4β7 Integrin Antagonist, Signed between EA P...

GlobeNewswire 06-27 Eldorado Gold Announces Extension and Increase of its Senior Secured Credit Facility

GlobeNewswire 06-27 Sachem Capital Corp. Announces Withdrawal of Public Debt Offering

GlobeNewswire 06-27 Inside Information: Nokia to acquire Infinera to increase scale in Optical Networks and accelerate p...

Newsfile Corp 06-27 AXTI FINAL DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages AXT, Inc. Investors to Secure Counsel...

GlobeNewswire 06-27 Exclusive Interview: Thor Equities Group Chairman Joe Sitt Discusses Post-Election Investment Strate...

GlobeNewswire 06-27 Kite Realty Group Trust Publishes Annual Corporate Responsibility Report

GlobeNewswire 06-27 Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial

Swiss Finance & Property Investme.../ CH0032816131 /

If you wish to receive reply to your feedback, please provide your email address.